Correlation Between Scpharmaceuticals and Gossamer Bio
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Gossamer Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Gossamer Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Gossamer Bio, you can compare the effects of market volatilities on Scpharmaceuticals and Gossamer Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Gossamer Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Gossamer Bio.
Diversification Opportunities for Scpharmaceuticals and Gossamer Bio
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Scpharmaceuticals and Gossamer is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Gossamer Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gossamer Bio and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Gossamer Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gossamer Bio has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Gossamer Bio go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Gossamer Bio
Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the Gossamer Bio. But the stock apears to be less risky and, when comparing its historical volatility, Scpharmaceuticals is 1.5 times less risky than Gossamer Bio. The stock trades about -0.01 of its potential returns per unit of risk. The Gossamer Bio is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 236.00 in Gossamer Bio on August 27, 2024 and sell it today you would lose (166.00) from holding Gossamer Bio or give up 70.34% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scpharmaceuticals vs. Gossamer Bio
Performance |
| Timeline |
| Scpharmaceuticals |
| Gossamer Bio |
Scpharmaceuticals and Gossamer Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and Gossamer Bio
The main advantage of trading using opposite Scpharmaceuticals and Gossamer Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Gossamer Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gossamer Bio will offset losses from the drop in Gossamer Bio's long position.| Scpharmaceuticals vs. Capricor Therapeutics | Scpharmaceuticals vs. Soleno Therapeutics | Scpharmaceuticals vs. Bio Path Holdings | Scpharmaceuticals vs. Moleculin Biotech |
| Gossamer Bio vs. Biomea Fusion | Gossamer Bio vs. Stoke Therapeutics | Gossamer Bio vs. Akero Therapeutics | Gossamer Bio vs. Replimune Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |